Completed PHASE2 INTERVENTIONAL 2-arm NCT02275611

Oxytocin Treatment of Alcohol Dependence (OT-ETOH2)

Oxytocin Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial

Sponsor: University of North Carolina, Chapel Hill

Conditions Alcohol Dependence Alcohol Withdrawal

Interventions Intranasal Placebo Spray intranasal oxytocin spray

Updated 7 times since 2017 Last updated: Mar 27, 2017 Started: Jan 31, 2013 Primary completion: Dec 31, 2013 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Alcohol Dependence and Alcohol Withdrawal and is currently completed. University of North Carolina, Chapel Hill leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
May 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — May 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of North Carolina, Chapel Hill

Data source: University of North Carolina, Chapel Hill

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.